| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . |
# |
Score |
Template |
Links and tools | %id | First |
MSETISEKSEGRVSYHDSVEEMVKKIREDGMSNVFDRYALQEKIRCKFCLEGLSCQLCSNGPCRISEKTGQEKGVCGIGPDAMAMRNFLLKNIMGAGTYSHHAYEAYRTLKATAEGRTPFKITDENKLKWMCEKLGIDTAQSINDMAFELAVILEDQQRIGVEDQNVMVEAFAPKKRIEAWKKLGIYPAGTVHEEQNCVASCLTNVDGSHISLAMKALRLGIATIYNTQIGLEMVQDILFGTPTPHEVNMDLGIMDPEYVNIVFNGHQPWIGAATILKAKTPEIQDMAKQAGAKGLRVVGSIETGQELLQRFPVDEVFVGHMGNWLAIEPLLATGTVDIFAMEENCSPPAIDMYAEKYQVTLAAVSTIIDLPGVNYKFPYDPAQADETAQRLIELGIENFKKRKERQIKPHVPQKIQKAIAGFSTEAVLGALGNKLDPLVDVIAKGQIKGVVALANCSTLRNGPQDWVTINLTKELIKRDILVVSGGCGNHALEVAGLCTLDAANNIAGNGLKAVCNALKIPPVLSFGTCTDTGRISMLVTALAEHLNVDVPQLPIAVTAPEWMEQKATIDGIFALAYGAYTHLSPTPFMTGARQLVDLLTNKAEDVTGGKIALGDDPMKVANDIEDHIMRKRKELGLS | Last |
1 | -80.800 | PF03063.20; R6MRD8_9BACE/5-545; Prismane/CO dehydrogenase family |
ali follow.. |
18 | 1 | ....................................................MFCYQCQEAAKGT---GCVLKGVCGKNSSTARYMDLLLFTVRGVSVAASALREQSVKVAAEVDSFVNANFDDESILRRVEKGIALRDDRGITLPEVDELEWKGEKDSFEEKAASVGVLREVNEDLRSLKELLVYGLKGMAAYH---EHAMRLGYNSEEIHAFMQAALAKIADEWVAQVMQAGEMGVKVMALLDEANTTRYGNPEITKVNIGVGKNPGI----LISGHDLHDIEDLLKQTEGTGVDVYTHSEMPAHYYPAFKKYKHFVGNYGNAWWKQREEFTAFNGPIVFTTNCIVPPL---SNATYKERMFTGNSTGYPGCKHIET--GADGHKDYSEVIALAKQCQPPV---------ELETGEIIGGFAHNQVL----QLADKVVEAVKSGAIRRFVVMAGCDGRMKSRD---YYTDFAKALPQDTVILTAGCAKYKYNKLPLGDIN-----------------GIPRVLDAGQCNDSYSLAVIALKLKEVFQLDINELPITYNIA-WYEQKAVIVLLALLSLGVKIHLGPTLPAFLSPNVAKVLVDTFG--IGGITTVDEDLK.................... |
541 |
2 | -6.640 | PF18133.1; A2FFR8_TRIVA/313-432; Hydrogen maturase F tetramerization domain |
ali follow.. |
11 | 7 | .....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................IDTLANLKKGDKVLICETCNHDRIGD--VQIPTKLKKMYPDVEIDWAFGRAYEDALHCGGCMISKQQMNARIQDLAESGVPISNYGLALS................................................................................ |
106 |
3 | -6.380 | PF07327.11; Q966Y0_SCHGR/1-102; Neuroparsin |
ali follow.. |
20 | 37 | .......................................VVDLTRCEYGEVTDFFKVCAKGP----SEHCNDFIKCGDGLRCNCGR......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
81 |
4 | -6.340 | PF13528.6; H8MS55_CORCM/1-323; Glycosyl transferase family 1 |
ali follow.. |
9 | 1 | ...................................................................................................................................................................................................................................................................MRILYGGH-ATRSRVLLEALKEHEVAQRFNVHGIWGLTIAYEGNSVKKWQTVLQNLQGVAGWPQNVRQYFDLVEGFKPDVVVSDFE---TFSYLFAKRHMLPVISVDNMQIINRCTHDPALLAGHEESFSRAIVKAKLPGAFHYLTTTFFPPVRKRRTTLAPSILRPEILAAKPEAGEHLLVYQTATTNTHLPEIL--VDGNLTYRPFSEAGFIDDLRTARAVVAGGGYTLMS-EAVYLRKPLLSIPVGGQFEQVL----NALYLERLGYGMYVKEL-------LDALKTFLSRVP.................................................................................... |
314 |
5 | -6.170 | PF14380.6; Q5N7Q6_ORYSJ/181-286; Wall-associated receptor kinase C-terminal |
ali follow.. |
13 | 38 | IVVPVNGSILNSSSQSALPSGEYGQVLKKGFELAWKSRKDKQ------------CNLCE-----------QSRGQCAYSQNR---TFLGCLCADG................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
106 |
6 | -6.010 | PF00290.20; TRPA_MAIZE/94-347; Tryptophan synthase alpha chain |
ali follow.. |
12 | 16 | .............................................................................................................................................................................................................................................ITAGDPDLATTAEALRLLDGCGADVIELGSDPYIDGPIIQASVARAL--------ASGTTMDAVLEMLREVTPELSCPVVLLSYYKPIMSRAEMKEAGVHGLIVPDL---AHSLWSEAKNNNLELVLTTPAIPEDRMKEITKASEGFVYLVSVNGVTGPRANVNPRVESLIQEVKKVTNKPVAVGFGISK-----PEHVKQIAQWGADGVIIGSAMVRQLGEAASPKQGLRRLEEYARGMKNAL.............................................................................................................................................................. |
253 |
7 | -5.950 | PF04885.13; M4CFF0_BRARP/12-161; Stigma-specific protein, Stig1 |
ali follow.. |
14 | 89 | ...................................NKCMDLSADDKNCGACKNKCQTCCRGQCVYVAYDKRHCGECNHRCNLGEL------CVYGLCNYA........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
150 |
8 | -5.720 | PF01039.22; MCCB_ARATH/93-585; Carboxyl transferase domain |
ali follow.. |
10 | 48 | ............................................................................................................................................................................................................................................................GIGPIHGRICMFMANDPTVKGGTYYPITIKKHLRAQEIAARCRLPCIYLVDSGGAYLPKQAEVFPDKENFGRVFYNESVMSSDGIPQIIVLGSCTAGGAYIPAMADESVMVKGNGTIFLAGPPLVEEVSAEDLGGATVHCTVSGVSDYFAQDELHGLAIGRNIVKNLHMAAKQGMEGTFGSKNLVYKEPLYDINELRSIA-------PVDHKQQFDVRSIIARIVDGSEFDLVTGFARIYIGNNGILFNESALKGAH--FIELCSQRKIPLVFMVGSRAEANGIAKAGAKMVMAVS---AKVPKITII-----GASFGAGNYAMC-AAGVLTQIERATKKRQKWTEEEEEAFKKKTVDAYEREANPYYSTARDDGVIDDTRKVL... |
473 |
9 | -5.560 | PF02318.16; H3DKF6_TETNG/7-124; FYVE-type zinc finger |
ali follow.. |
11 | 15 | VQRDFDLRKKEEDRLGDLKTKIQKEDTKRELLGNQSRLTESYCIRCLLVNTKRQCLDCQLHICKSCSRYNKRE-PCHMARVLKIGT......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
110 |
10 | -5.560 | PF12225.8; F2NGT9_DESAR/111-205; Methylene-tetrahydrofolate reductase C terminal |
ali follow.. |
30 | 27 | ............................................KCILASTGGICARCSKGPC-----GGSEKGKCEVNPDIDCGWQLIFDRLKILG.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
80 |